Early research (Phase 1)Study completedNCT02382913What this trial is testingPersistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)Who this might be right forPertussis Novartis 315
Not applicableStudy completedNCT02569879What this trial is testingImpact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.Who this might be right forDiphtheriaAcellular PertussisTetanus+2 more GlaxoSmithKline 1
Large-scale testing (Phase 3)Active Not RecruitingNCT06857370What this trial is testingInter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined VaccineWho this might be right forDiphtheria, Tetanus and Acellular Pertussis CanSino Biologics Inc. 780
Post-approval studies (Phase 4)Study completedNCT02783170What this trial is testingSafety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant WomenWho this might be right forPregnancy Duke University 81
Not applicableStudy completedNCT02447978What this trial is testingDuration of Protection: GSK DTaP VaccinesWho this might be right forDiphtheriaAcellular PertussisTetanus GlaxoSmithKline 1
Not applicableStudy completedNCT03824093What this trial is testingHigh and Low Resource Interventions to Promote HPV VaccinesWho this might be right forHuman Papilloma VirusTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationMeningitis, Meningococcal+2 more Children's Mercy Hospital Kansas City 225
Large-scale testing (Phase 3)Study completedNCT01287949What this trial is testingSafety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or OlderWho this might be right forDiphtheriaTetanusPoliomyelitis+1 more Sanofi Pasteur, a Sanofi Company 342
Post-approval studies (Phase 4)Study completedNCT00282295What this trial is testingUS-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal DiseaseWho this might be right forAcellular PertussisTetanusDiphtheria GlaxoSmithKline 1,344
Large-scale testing (Phase 3)Looking for participantsNCT06344065What this trial is testingImmunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old InfantsWho this might be right forHealthy Volunteers Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 1,584
Large-scale testing (Phase 3)Study completedNCT00263679What this trial is testingAssessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.Who this might be right forAcellular PertussisDiphtheriaTetanus GlaxoSmithKline 321
Large-scale testing (Phase 3)Study completedNCT00290342What this trial is testingEvaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy InfantsWho this might be right forTetanusAcellular PertussisDiphtheria GlaxoSmithKline 458
Large-scale testing (Phase 3)Study completedNCT00489970What this trial is testingPersistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9Who this might be right forAcellular PertussisTetanusDiphtheria GlaxoSmithKline 1,954
Early research (Phase 1)Looking for participantsNCT07203755What this trial is testingClinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined VaccineWho this might be right forDiphtheria, Tetanus and Acellular PertussisEpidemic MeningitisHaemophilus Influenzae Type B Infection CanSino Biologics Inc. 260
Not applicableStudy completedNCT00908115What this trial is testingPost Market Surveillance for Infanrix™Who this might be right forDiphtheriaAcellular PertussisTetanus GlaxoSmithKline 1,258
Testing effectiveness (Phase 2)Study completedNCT00263692What this trial is testingComparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and SafetyWho this might be right forDiphtheriaAcellular PertussisTetanus GlaxoSmithKline 401
Post-approval studies (Phase 4)Study completedNCT01294605What this trial is testingImmunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV)Who this might be right forAcellular PertussisTetanusDiphtheria GlaxoSmithKline 460
Large-scale testing (Phase 3)Study completedNCT00379977What this trial is testingStudy to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of AgeWho this might be right forTetanusHaemophilus Influenzae Type bAcellular Pertussis+1 more GlaxoSmithKline 30
Large-scale testing (Phase 3)Study completedNCT01577732What this trial is testingSafety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese ToddlersWho this might be right forAcellular PertussisHaemophilus Influenzae Type bTetanus+3 more GlaxoSmithKline 321
Large-scale testing (Phase 3)Study completedNCT01346293What this trial is testingStudy of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of AgeWho this might be right forTetanusDiphtheriaPertussis+2 more Sanofi Pasteur, a Sanofi Company 3,372
Post-approval studies (Phase 4)Study completedNCT00255021What this trial is testingImmunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in ThailandWho this might be right forDiphtheriaTetanusPoliomyelitis+2 more Sanofi 186